Pharmaceutical

Recent TVM settlements, verdicts may lead to resolution in outstanding MDL

mesh Recent TVM settlements, verdicts may lead to resolution in outstanding MDLA number of high-profile transvaginal mesh settlements and verdicts in the past few months may prompt larger larger-scale settlements in the multidistrict litigation (MDL) in West Virginia. That MDL involves pelvic mesh devices manufactured by a several medical device companies including C.R. Bard Inc., and Johnson & Johnson subsidiary Ethicon Inc.

Last month, American Medical Systems announced it had resolved more than 100 personal injury lawsuits with the $830 million the company had set aside to settle a large number of the lawsuits waged against its transvaginal mesh device.

In May, Boston Scientific Corp., was ordered to pay $100 million in a lawsuit in state court in Delaware in which a woman claimed she suffered serious injuries from the company’s Advantage Fit and Pinnacle transvaginal mesh.

Transvaginal mesh is a type of surgical mesh that is used to treat pelvic organ prolapse and stress urinary incontinence. The Food and Drug Administration (FDA) has warned that complications with the devices are not uncommon and include erosion into tissue and protrusion into organs, causing patients to suffer chronic pain, infections, incontinence, hemorrhages, organ and/or tissue damage, and disability.

Attorneys say that the recent TVM settlements and verdicts that have fallen in favor of plaintiffs would suggest that some type of global settlement of the claims is in the works. However, the settlement would have to recognize each individual defendant’s potential liability, plaintiffs attorneys say.

Source: Law360